| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.11 (Beat by $0.39) |
| EPS GAAP Actual | $1.11 (Beat by $0.39) |
| Revenue Actual | $1.232B |
| Revenue Surprise | Beat by $1232M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.93918 |
| EPS GAAP Estimate | $2.93918 |
| Revenue Estimate | $0.415663753B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 6.99655 | 8 | 6.84483 | 7.13669 | 1 |
| Dec 2025 | 6.20589 | 9.02 | 5.88 | 6.66357 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.7 | -0.92756 | 1.232B | -0.41% | 884.74M |
| FQ2 2025 (Jun 2025) | 0.77 | 0.77 | 1.238B | 0.97% | 1238M |
| FQ1 2025 (Mar 2025) | 1.72 | 1.72 | 1.292B | 2.17% | 1292M |
| FQ4 2024 (Dec 2024) | -0.46 | -0.46 | 1.326B | 6.11% | 1326M |
| FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 1.237B | 1.21% | 1237M |
| FQ4 2012 (Dec 2012) | 0.17 | 0.17 | 0.322202B | 100% | 322.2M |
| FQ2 2024 (Jun 2024) | 1.2 | 1.2 | 1.226B | 1.39% | 1226M |
| FQ1 2024 (Mar 2024) | 1.78 | 1.78 | 1.264B | 1.42% | 1264M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.93918
Consensus Revenue Estimates
0.415663753B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.51669 | -- | 0.48908 | 0.5461 | 1 |
| FQ3 2027 (Sep 2027) | 1.84748 | -- | 1.78214 | 1.9175 | 1 |
| FQ2 2027 (Jun 2027) | 2.09186 | -- | 2.01787 | 2.17114 | 1 |
| FQ1 2027 (Mar 2027) | 2.4915 | -- | 2.40338 | 2.58592 | 1 |
| FQ4 2026 (Oct 2026) | 1.93368 | -- | 1.8962 | 1.96981 | 1 |
| FQ3 2026 (Jul 2026) | 1.77803 | 60.63 | 1.74357 | 1.81125 | 1 |
| FQ2 2026 (Jun 2026) | 1.77803 | 56.69 | 1.75978 | 1.79656 | 1 |
| FQ1 2026 (Mar 2026) | 2.93918 | 41.48 | 2.90902 | 2.96982 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.27B | -- | 0.26B | 0.28B | 2 |
| FQ3 2027 (Sep 2027) | 0.3B | -- | 0.29B | 0.31B | 2 |
| FQ2 2027 (Jun 2027) | 0.31B | -- | 0.3B | 0.31B | 2 |
| FQ1 2027 (Mar 2027) | 0.33B | -- | 0.32B | 0.33B | 2 |
| FQ4 2026 (Oct 2026) | 0.36B | -- | 0.35B | 0.36B | 1 |
| FQ3 2026 (Jul 2026) | 0.36B | -245.33 | 0.35B | 0.36B | 1 |
| FQ2 2026 (Jun 2026) | 0.36B | -247.01 | 0.35B | 0.36B | 1 |
| FQ1 2026 (Mar 2026) | 0.42B | -210.83 | 0.41B | 0.42B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.62756 | 0.7 | -0.92756 | -132.51% |
| FQ2 2025 (Jun 2025) | 0.77 | 0.77 | 100% | |
| FQ1 2025 (Mar 2025) | 1.72 | 1.72 | 100% | |
| FQ4 2024 (Dec 2024) | -0.46 | -0.46 | 100% | |
| FQ3 2024 (Sep 2024) | 0.9 | 0.9 | 100% | |
| FQ4 2012 (Dec 2012) | 0.17 | 0.17 | 100% | |
| FQ2 2024 (Jun 2024) | 1.2 | 1.2 | 100% | |
| FQ1 2024 (Mar 2024) | 1.78 | 1.78 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.35B | $1.23B | $884.74M | 71.81% |
| FQ2 2025 (Jun 2025) | $0B | $1.24B | $1238M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.29B | $1292M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.33B | $1326M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.24B | $1237M | 100% |
| FQ4 2012 (Dec 2012) | $0B | $0.32B | $322.2M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.23B | $1226M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.26B | $1264M | 100% |